Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO. 2 TO FORM S-1 - AMBIT BIOSCIENCES CORP | d447329ds1a.htm |
| EX-1.1 - EX-1.1 - AMBIT BIOSCIENCES CORP | d447329dex11.htm |
| EX-4.1 - EX-4.1 - AMBIT BIOSCIENCES CORP | d447329dex41.htm |
| EX-10.2 - EX-10.2 - AMBIT BIOSCIENCES CORP | d447329dex102.htm |
| EX-10.4 - EX-10.4 - AMBIT BIOSCIENCES CORP | d447329dex104.htm |
| EX-10.3 - EX-10.3 - AMBIT BIOSCIENCES CORP | d447329dex103.htm |
| EX-10.17 - EX-10.17 - AMBIT BIOSCIENCES CORP | d447329dex1017.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the reference to our firm under the caption “Experts” and the use of our report dated February 20, 2013, except Note 11, as to which the date is March 26, 2013 and except for the retroactive effect of the 24-for-1 reverse stock split as described in Note 1, as to which the date is April 24, 2013, in the Registration Statement Amendment No. 2 on Form S-1 and related Prospectus of Ambit Biosciences Corporation dated April 24, 2013.
/s/ Ernst & Young LLP
San Diego, California
April 24, 2013